Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2020

01-04-2020 | Myocardial Infarction

Physical exertion as a trigger of acute coronary syndrome caused by plaque erosion

Authors: Ayami Kato, Yoshiyasu Minami, Aritomo Katsura, Yusuke Muramatsu, Toshimitsu Sato, Ryota Kakizaki, Teruyoshi Nemoto, Takuya Hashimoto, Kazuhiro Fujiyoshi, Kentaro Meguro, Takao Shimohama, Junya Ako

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2020

Login to get access

Abstract

Distinct clinical characteristics have been demonstrated in patients with plaque erosion as compared with those with plaque rupture. We reasoned that greater physical activity might influence the onset of plaque erosion. In total, 97 consecutive patients with non ST-segment elevation acute coronary syndrome (ACS) who underwent optical coherence tomography (OCT) imaging of the culprit lesion were enrolled. OCT-determined culprit plaque characteristics were plaque erosion (18.6%), calcified plaque (26.8%), plaque rupture (32.0%) and other (22.7%). The physical activity evaluated by estimated metabolic equivalents (METs) at ACS onset was significantly greater in the plaque erosion group than in the plaque rupture group (3.3 ± 1.7 vs. 2.1 ± 1.0, p = 0.011). The rate of ACS onset outdoors was the highest (61.1%) in the plaque erosion group. The combination of greater physical activity (> 3 METs), outdoor onset and higher body mass index (> 25.1 kg/m2) had a significant odds ratio for the incidence of plaque erosion (odds ratio 15.0, 95% confidence interval 3.81 to 59.0, p < 0.001). Plaque erosion was associated with greater physical activity at the onset. This finding may help to further clarify the pathogenesis of ACS

Graphic abstract

Impact of physical exertion on the incidence of plaque erosion. NSTE-ACS, non ST-segment elevation acute coronary syndrome.
Appendix
Available only for authorised users
Literature
1.
go back to reference Virmani R, Kolodgie FD, Burke AP et al (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arter Thromb Vasc Biol 20:1262–1275CrossRef Virmani R, Kolodgie FD, Burke AP et al (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arter Thromb Vasc Biol 20:1262–1275CrossRef
3.
go back to reference Higuma T, Soeda T, Abe N et al (2015) A Combined optical coherence tomography and Intravascular Ultrasound Study on Plaque Rupture, Plaque Erosion, and calcified nodule in patients with ST-segment elevation myocardial infarction: incidence, morphologic characteristics, and outcomes after perc. JACC Cardiovasc Interv 8:1166–1176. https://doi.org/10.1016/j.jcin.2015.02.026 CrossRefPubMed Higuma T, Soeda T, Abe N et al (2015) A Combined optical coherence tomography and Intravascular Ultrasound Study on Plaque Rupture, Plaque Erosion, and calcified nodule in patients with ST-segment elevation myocardial infarction: incidence, morphologic characteristics, and outcomes after perc. JACC Cardiovasc Interv 8:1166–1176. https://​doi.​org/​10.​1016/​j.​jcin.​2015.​02.​026 CrossRefPubMed
8.
go back to reference Kolodgie FD, Burke AP, Farb A et al (2002) Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arter Thromb Vasc Biol 22:1642–1648CrossRef Kolodgie FD, Burke AP, Farb A et al (2002) Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arter Thromb Vasc Biol 22:1642–1648CrossRef
14.
go back to reference Smith SC, Feldman TE, Hirshfeld JW et al (2006) ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention). J Am Coll Cardiol 47:216–235CrossRef Smith SC, Feldman TE, Hirshfeld JW et al (2006) ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention). J Am Coll Cardiol 47:216–235CrossRef
17.
go back to reference Giri S, Thompson PD, Kiernan FJ et al (1999) Clinical and angiographic characteristics of exertion-related acute myocardial infarction. JAMA 282:1731–1736CrossRef Giri S, Thompson PD, Kiernan FJ et al (1999) Clinical and angiographic characteristics of exertion-related acute myocardial infarction. JAMA 282:1731–1736CrossRef
19.
go back to reference Chicharro JL, Sánchez O, Bandrés F et al (1994) Platelet aggregability in relation to the anaerobic threshold. Thromb Res 75:251–257CrossRef Chicharro JL, Sánchez O, Bandrés F et al (1994) Platelet aggregability in relation to the anaerobic threshold. Thromb Res 75:251–257CrossRef
32.
go back to reference Burke AP, Farb A, Malcom GT et al (1998) Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 97:2110–2116CrossRef Burke AP, Farb A, Malcom GT et al (1998) Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 97:2110–2116CrossRef
Metadata
Title
Physical exertion as a trigger of acute coronary syndrome caused by plaque erosion
Authors
Ayami Kato
Yoshiyasu Minami
Aritomo Katsura
Yusuke Muramatsu
Toshimitsu Sato
Ryota Kakizaki
Teruyoshi Nemoto
Takuya Hashimoto
Kazuhiro Fujiyoshi
Kentaro Meguro
Takao Shimohama
Junya Ako
Publication date
01-04-2020
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2020
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-020-02074-y

Other articles of this Issue 3/2020

Journal of Thrombosis and Thrombolysis 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.